Quintiles and Biogen Idec have entered into a five-year strategic clinical development agreement and multi-year collaboration aimed at optimizing Biogen’s clinical development processes.   The collaboration will focus on clinical trial efficiency, transparency, quality, innovation and operational excellence. Quintiles will work with Biogen on the design, planning and execution of Biogen’s Phase II-IV studies and select Phase I studies. Biogen will also leverage Quintiles’ technology and systems....